Trademark: 77783924
Word
EE
Status
Dead
Status Code
606
Status Date
Monday, October 3, 2011
Serial Number
77783924
Mark Type
5000
Filing Date
Friday, July 17, 2009
Published for Opposition
Tuesday, December 8, 2009
Abandoned Date
Monday, October 3, 2011

Trademark Owner History
Epigenesis Pharmaceuticals, LLC - Owner At Publication

Classifications
5 medical diagnostic and therapeutic preparations for clinical use, all for administration via diverse routes of administration including through the respiratory airways, and, medical devices for administering the pharmaceuticals, sold as a kit, namely, inhalers; medical preparations, namely, nucleotides, proteins and organic molecules for medical use, including macromolecules such as anti-sense oligonucleotides and enzymes and small and inorganic molecules for treatment of human and non-human animal respiratory, central nervous system, neoplastic, endocrine, immune and cardiovascular ailments, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, which in some cases are adenosine receptor associated symptoms; pharmaceutical preparations for testing, and preventing and therapeutically treating respiratory, airway and pulmonary diseases and conditions, such as asthma, pulmonary vasconconstriction, inflammation, allergies, impeded respiration, acute respiratory disease syndrome (ARDS), renal damage and failure, ischemia resulting from the administration of certain drugs, including adenosine and other drugs for, for example, treating supra ventricular tachycardia (SVT), adenosine stress tests, infantile respiratory distress syndrome (infantile RDS), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vasconcontriction, emphysema, chronic obstructive pulmonary disease (COPD), as well as cancers including leukemias, lymphomas, carcinomas, and the like, eg colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, etc, as well as metastatic cancers, eg, cancers which metastasized to the lung(s), breast, liver and prostate
Color is not claimed as a feature of the mark.
The mark consists of The mark consists of stylized letter "E" connected to another transposed stylized letter "E" in a top to bottom alignment.
EPIGENESIS

Trademark Events
Oct 21, 2011
Undeliverable Mail - No Action Taken
Oct 3, 2011
Abandonment Notice Mailed - No Use Statement Filed
Oct 3, 2011
Abandonment - No Use Statement Filed
May 5, 2011
Withdrawal Of Attorney Granted
May 5, 2011
Teas Withdrawal Of Attorney Received
Mar 12, 2011
Notice Of Approval Of Extension Request E-Mailed
Mar 11, 2011
Extension 2 Granted
Mar 1, 2011
Extension 2 Filed
Mar 11, 2011
Case Assigned To Intent To Use Paralegal
Mar 1, 2011
Teas Extension Received
Sep 2, 2010
Notice Of Approval Of Extension Request E-Mailed
Aug 31, 2010
Extension 1 Granted
Aug 31, 2010
Extension 1 Filed
Aug 31, 2010
Teas Extension Received
Mar 2, 2010
Noa Mailed - Sou Required From Applicant
Dec 8, 2009
Official Gazette Publication Confirmation E-Mailed
Dec 8, 2009
Published For Opposition
Nov 3, 2009
Law Office Publication Review Completed
Nov 3, 2009
Assigned To Lie
Oct 19, 2009
Approved For Pub - Principal Register
Oct 19, 2009
Assigned To Examiner
Jul 22, 2009
Notice Of Pseudo Mark Mailed
Jul 21, 2009
New Application Office Supplied Data Entered In Tram
Jul 21, 2009
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24